质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
Product photo — to be added
Rx
肿瘤学 & 血液学

ALIREVMENI 110mg

瑞伏美尼 (Revumenib)
Generic (INN)
瑞伏美尼 (Revumenib)
Strength
110 mg
Packaging
30片/瓶。
Indication
ALIREVMENI 是一种 Menin 抑制剂，用于治疗 1 岁及以上伴有赖氨酸甲基转移酶 2A 基因（KMT2A）易位的复发或难治性急性白血病成人和儿童患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALICAPASE
ALICAPASE
卡匹色替 (Capivasertib)
ALITRAMETINIB
ALITRAMETINIB
曲美替尼 (Trametinib)
ALIMACATEN
ALIMACATEN
玛伐凯泰 (Mavacamten)
ALIPITOBTINIB
ALIPITOBTINIB
吡托布鲁替尼 (Pirtobrutinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文